vs

Side-by-side financial comparison of BENTLEY SYSTEMS INC (BSY) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

BENTLEY SYSTEMS INC is the larger business by last-quarter revenue ($424.2M vs $321.1M, roughly 1.3× MADRIGAL PHARMACEUTICALS, INC.). BENTLEY SYSTEMS INC runs the higher net margin — 22.5% vs -18.2%, a 40.7% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 14.5%). BENTLEY SYSTEMS INC produced more free cash flow last quarter ($187.9M vs $-133.8M).

Bentley Systems, Incorporated is a US-based software development company that develops, manufactures, licenses, sells and supports computer software and services for the design, construction, and operation of infrastructure globally. The company's software serves the building, plant, civil, and geospatial markets in the areas of architecture, engineering, construction (AEC) and operations. Their software products are used to design, engineer, build, and operate large constructed assets such a...

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

BSY vs MDGL — Head-to-Head

Bigger by revenue
BSY
BSY
1.3× larger
BSY
$424.2M
$321.1M
MDGL
Growing faster (revenue YoY)
MDGL
MDGL
+196.3% gap
MDGL
210.8%
14.5%
BSY
Higher net margin
BSY
BSY
40.7% more per $
BSY
22.5%
-18.2%
MDGL
More free cash flow
BSY
BSY
$321.7M more FCF
BSY
$187.9M
$-133.8M
MDGL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BSY
BSY
MDGL
MDGL
Revenue
$424.2M
$321.1M
Net Profit
$95.3M
$-58.6M
Gross Margin
82.6%
Operating Margin
29.8%
-18.6%
Net Margin
22.5%
-18.2%
Revenue YoY
14.5%
210.8%
Net Profit YoY
4.4%
1.4%
EPS (diluted)
$0.30
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BSY
BSY
MDGL
MDGL
Q1 26
$424.2M
Q4 25
$391.6M
$321.1M
Q3 25
$375.5M
$287.3M
Q2 25
$364.1M
$212.8M
Q1 25
$370.5M
$137.3M
Q4 24
$349.8M
$103.3M
Q3 24
$335.2M
$62.2M
Q2 24
$330.3M
Net Profit
BSY
BSY
MDGL
MDGL
Q1 26
$95.3M
Q4 25
$58.6M
$-58.6M
Q3 25
$57.4M
$-114.2M
Q2 25
$70.5M
$-42.3M
Q1 25
$91.4M
$-73.2M
Q4 24
$50.1M
$-59.4M
Q3 24
$42.3M
$-107.0M
Q2 24
$72.0M
Gross Margin
BSY
BSY
MDGL
MDGL
Q1 26
82.6%
Q4 25
81.9%
Q3 25
80.8%
Q2 25
81.1%
Q1 25
82.3%
96.7%
Q4 24
80.6%
Q3 24
80.7%
Q2 24
80.9%
Operating Margin
BSY
BSY
MDGL
MDGL
Q1 26
29.8%
Q4 25
20.0%
-18.6%
Q3 25
22.5%
-39.7%
Q2 25
23.2%
-22.2%
Q1 25
31.1%
-57.8%
Q4 24
17.6%
-64.8%
Q3 24
20.5%
-187.1%
Q2 24
24.3%
Net Margin
BSY
BSY
MDGL
MDGL
Q1 26
22.5%
Q4 25
15.0%
-18.2%
Q3 25
15.3%
-39.8%
Q2 25
19.4%
-19.9%
Q1 25
24.7%
-53.4%
Q4 24
14.3%
-57.5%
Q3 24
12.6%
-172.0%
Q2 24
21.8%
EPS (diluted)
BSY
BSY
MDGL
MDGL
Q1 26
$0.30
Q4 25
$0.17
$-2.55
Q3 25
$0.18
$-5.08
Q2 25
$0.22
$-1.90
Q1 25
$0.28
$-3.32
Q4 24
$0.15
$-2.50
Q3 24
$0.13
$-4.92
Q2 24
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BSY
BSY
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$105.2M
$198.7M
Total DebtLower is stronger
$1.1B
$339.9M
Stockholders' EquityBook value
$1.2B
$602.7M
Total Assets
$3.5B
$1.3B
Debt / EquityLower = less leverage
0.91×
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BSY
BSY
MDGL
MDGL
Q1 26
$105.2M
Q4 25
$123.3M
$198.7M
Q3 25
$165.4M
$295.7M
Q2 25
$89.6M
$186.2M
Q1 25
$83.6M
$183.6M
Q4 24
$64.0M
$100.0M
Q3 24
$72.2M
$232.7M
Q2 24
$51.3M
Total Debt
BSY
BSY
MDGL
MDGL
Q1 26
$1.1B
Q4 25
$1.2B
$339.9M
Q3 25
$1.2B
$339.8M
Q2 25
$1.2B
$118.4M
Q1 25
$1.2B
$118.0M
Q4 24
$1.4B
$117.6M
Q3 24
$1.4B
$117.1M
Q2 24
$1.3B
Stockholders' Equity
BSY
BSY
MDGL
MDGL
Q1 26
$1.2B
Q4 25
$1.2B
$602.7M
Q3 25
$1.2B
$625.7M
Q2 25
$1.2B
$696.0M
Q1 25
$1.1B
$710.6M
Q4 24
$1.0B
$754.4M
Q3 24
$1.0B
$777.2M
Q2 24
$984.5M
Total Assets
BSY
BSY
MDGL
MDGL
Q1 26
$3.5B
Q4 25
$3.6B
$1.3B
Q3 25
$3.5B
$1.4B
Q2 25
$3.4B
$1.0B
Q1 25
$3.4B
$996.6M
Q4 24
$3.4B
$1.0B
Q3 24
$3.4B
$1.1B
Q2 24
$3.3B
Debt / Equity
BSY
BSY
MDGL
MDGL
Q1 26
0.91×
Q4 25
1.05×
0.56×
Q3 25
1.04×
0.54×
Q2 25
1.07×
0.17×
Q1 25
1.13×
0.17×
Q4 24
1.33×
0.16×
Q3 24
1.37×
0.15×
Q2 24
1.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BSY
BSY
MDGL
MDGL
Operating Cash FlowLast quarter
$193.4M
$-133.5M
Free Cash FlowOCF − Capex
$187.9M
$-133.8M
FCF MarginFCF / Revenue
44.3%
-41.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
2.03×
TTM Free Cash FlowTrailing 4 quarters
$491.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BSY
BSY
MDGL
MDGL
Q1 26
$193.4M
Q4 25
$141.6M
$-133.5M
Q3 25
$116.4M
$79.8M
Q2 25
$61.1M
$-47.1M
Q1 25
$219.4M
$-88.9M
Q4 24
$81.6M
$-104.5M
Q3 24
$86.1M
$-67.0M
Q2 24
$62.6M
Free Cash Flow
BSY
BSY
MDGL
MDGL
Q1 26
$187.9M
Q4 25
$136.2M
$-133.8M
Q3 25
$110.7M
$79.0M
Q2 25
$57.0M
Q1 25
$216.4M
Q4 24
$76.1M
$-104.7M
Q3 24
$84.3M
$-67.8M
Q2 24
$59.5M
FCF Margin
BSY
BSY
MDGL
MDGL
Q1 26
44.3%
Q4 25
34.8%
-41.7%
Q3 25
29.5%
27.5%
Q2 25
15.7%
Q1 25
58.4%
Q4 24
21.7%
-101.3%
Q3 24
25.1%
-109.0%
Q2 24
18.0%
Capex Intensity
BSY
BSY
MDGL
MDGL
Q1 26
Q4 25
1.4%
0.1%
Q3 25
1.5%
0.3%
Q2 25
1.1%
0.0%
Q1 25
0.8%
0.0%
Q4 24
1.6%
0.2%
Q3 24
0.5%
1.3%
Q2 24
0.9%
Cash Conversion
BSY
BSY
MDGL
MDGL
Q1 26
2.03×
Q4 25
2.41×
Q3 25
2.03×
Q2 25
0.87×
Q1 25
2.40×
Q4 24
1.63×
Q3 24
2.03×
Q2 24
0.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BSY
BSY

Subscriptions$392.5M93%
Services$22.6M5%
Perpetual licenses$9.1M2%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons